The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his ...

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his ...

Mounjaro (tirzepatide) is a once-weekly injection that is said to be one of the most effective weight loss medications available. A recent study found that individuals taking Mounjaro lost 42% more ...

THE NHS is set to dish out Mounjaro prescriptions to more patients, as private clinics prepare to double their prices from ...

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh ...

The company said Friday that it received FDA approval for a new Wegovy indication as a treatment of a fatty liver disease known as metabolic dysfunction-associated steatohepatitis, or MASH, in adults ...

Novo Nordisk shares climbed in premarket trading Monday after the U.S. Food and Drug Administration granted accelerated ...

Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, warned it is 'crucial' to transition under ...

The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain ...

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

Analysis - Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world.